Detalhe da pesquisa
1.
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
N Engl J Med
; 388(9): 813-823, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856617
2.
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
N Engl J Med
; 386(1): 24-34, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34986285
3.
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial.
Lancet Oncol
; 25(5): 588-602, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38608691
4.
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.
Cancer
; 130(10): 1784-1796, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261444
5.
A Pathogenic Th17/CD38+ Macrophage Feedback Loop Drives Inflammatory Arthritis through TNF-α.
J Immunol
; 208(6): 1315-1328, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35197330
6.
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
N Engl J Med
; 381(16): 1535-1546, 2019 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562797
7.
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Lancet Oncol
; 22(12): 1692-1704, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774225
8.
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
N Engl J Med
; 379(8): 722-730, 2018 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30134131
9.
The receptor Ly108 functions as a SAP adaptor-dependent on-off switch for T cell help to B cells and NKT cell development.
Immunity
; 36(6): 986-1002, 2012 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-22683125
10.
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
N Engl J Med
; 377(14): 1345-1356, 2017 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28889792
11.
ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6.
Immunity
; 34(6): 932-46, 2011 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21636296
12.
The gradient of the reinforcement landscape influences sensorimotor learning.
PLoS Comput Biol
; 15(3): e1006839, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30830902
13.
Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.
BMC Cancer
; 19(1): 366, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30999949
14.
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.
Lancet Oncol
; 19(11): 1480-1492, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30361170
15.
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
N Engl J Med
; 373(1): 23-34, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26027431
16.
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
Cancer
; 123(14): 2688-2697, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28334439
17.
Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis.
Oncologist
; 22(6): 709-718, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28495807
18.
Efficacy and Outcome of Tofacitinib in Immune checkpoint Inhibitor Colitis.
Gastroenterology
; 160(3): 932-934.e3, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33096100
19.
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.
BMC Cancer
; 17(1): 332, 2017 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28511673
20.
Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents.
Oncologist
; 21(10): 1230-1240, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401894